+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Efavirenz (CAS 154598-52-4) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4172262
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Efavirenz. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Efavirenz global market report's key points:

  • Efavirenz description, applications and related patterns
  • Efavirenz market situation
  • Efavirenz manufacturers and distributors
  • Efavirenz prices
  • Efavirenz end-users
  • Efavirenz downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Efavirenz end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Efavirenz market trends and forecast, distinguish Efavirenz manufacturers and suppliers.

The sixth chapter provides Efavirenz prices data.

The seventh chapter analyses Efavirenz downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. EFAVIRENZ GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. EFAVIRENZ APPLICATIONS

3. EFAVIRENZ MANUFACTURING METHODS

4. EFAVIRENZ PATENTS

5. EFAVIRENZ MARKET WORLDWIDE
5.1. Global Efavirenz market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Efavirenz
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Efavirenz
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. EFAVIRENZ MARKET PRICES
  • Europe
  • Asia
  • North America
7. EFAVIRENZ END-USE SECTOR

Related Topics

Related Reports

Pregnancy and Anti-Infective Agents - Product Image

Pregnancy and Anti-Infective Agents

  • Book
From
Abacavir (CAS 136470-78-5) Global Market Research Report 2024 - Product Image

Abacavir (CAS 136470-78-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Cilastatin (CAS 82009-34-5) Global Market Research Report 2024 - Product Image

Cilastatin (CAS 82009-34-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Hepatitis B Diagnostic Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Hepatitis B Diagnostic Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 87 Pages
  • Global
From
Abacavir Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Abacavir Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 86 Pages
  • Global
From

About the Efavirenz Market

Efavirenz is an antiretroviral drug used to treat HIV infection and AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by blocking the action of the enzyme reverse transcriptase, which is needed for HIV to replicate. Efavirenz is usually prescribed in combination with other antiretroviral drugs to reduce the amount of HIV in the body and prevent the development of drug resistance. It is also used to reduce the risk of HIV transmission from mother to child during pregnancy. Efavirenz is a widely used antiretroviral drug and is available in both generic and branded formulations. It is approved for use in adults and children over the age of three months. Common side effects of efavirenz include dizziness, insomnia, headache, and rash. Some companies in the efavirenz market include Merck, Bristol-Myers Squibb, Cipla, Mylan, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.